IPHA

Innate Pharma
IPHA

8 hedge funds and large institutions have $806K invested in Innate Pharma in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$274K

Top Sellers

1
-$41.7K
2
-$18.8K
3
-$6.27K
4
Morgan Stanley
Morgan Stanley
New York
-$5.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$481K
2
$119K
3
$114K
4
$88.5K
5
$1.26K
6
$1K
7
$518
8
$369
9
–